Starcoin Group Limited, an investment holding company, engages in the trading of beauty products in the People's Republic of China and Hong Kong. It operates in two segments, Trading of Beauty Products, and Research and Development. The company is also involved in the research, development, and commercialization of oral insulin products; and the provision of genetic testing services, as well as securities investment. In addition, it offers healthcare management and bio-industrial products distribution services. The company has a strategic cooperation agreement with Huamei Haibo Biotechnology (Chongqing) Co., Ltd for development in the biotechnology and healthcare sectors. The company was formerly known as Innovative Pharmaceutical Biotech Limited and changed its name to Starcoin Group Limited in August 2025. Starcoin Group Limited was incorporated in 2000 and is based in Central, Hong Kong.
Frequently asked questions
What sector does Innovative Pharmaceutical Biotech Ltd (0399) operate in?
Innovative Pharmaceutical Biotech Ltd belongs to the Industrials sector and operates in the Specialty Retail industry.
What is Innovative Pharmaceutical Biotech Ltd (0399) current stock price?
As of the latest data, Innovative Pharmaceutical Biotech Ltd stock price is HK$0.07, with a previous close of HK$0.07.
What is Innovative Pharmaceutical Biotech Ltd (0399) current market capitalization?
Innovative Pharmaceutical Biotech Ltd market cap is approximately 231.21 million.
What is Innovative Pharmaceutical Biotech Ltd (0399) Earnings Per Share (EPS)?
The trailing EPS is -HK$0.06.
Does Innovative Pharmaceutical Biotech Ltd (0399) pay dividends?
No. Innovative Pharmaceutical Biotech Ltd does not pay a dividend.
What is Innovative Pharmaceutical Biotech Ltd (0399) beta (volatility) score?
Innovative Pharmaceutical Biotech Ltd has a beta of 0.426, indicating lower volatility than the overall market.
